Cerebroprotective Potential of Andrographolide Nanoparticles: In silico and In vivo Investigations
Drug Research · 01.09.2024 · 74 (07) · 335-346
DOI: 10.1055/a-2345-5396 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Research, erschienen am 01.09.2024. Verfasst von Lakshmi Charitha Rudrala und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, SKU College of Pharmaceutical Sciences, S. K. University, Anantapur, India. Hauptthemen laut MEDLINE: Neuroprotective Agents, Nanoparticles, Diterpenes. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 38 Literaturangaben.
Abstract (Originalsprache)
Ischemic stroke remains the leading cause of death and disability, while the main mechanisms of dominant neurological damage in stroke contain oxidative stress and inflammation. Docking studies revealed a binding energy of − 6.1 kcal/mol for AG, while the co-crystallized ligand (CCl) exhibited a binding energy of − 7.3 kcal/mol with NOS. AG demonstrated favourable hydrogen bond interactions with amino acids ASN A:354 and ARG A:388 and hydrophobic interactions with GLU A:377. Molecular dynamics simulations throughout 100 ns indicated a binding affinity of − 27.65±2.88 kcal/mol for AG, compared to − 18.01±4.02 kcal/mol for CCl. These findings suggest that AG possesses a superior binding affinity for NOS compared to CCl, thus complementing the stability of NOS at the docked site.AG has limited applications owing to its low bioavailability, poor water solubility, and high chemical and metabolic instability.The fabrication method was employed in the preparation of AGNP, SEM analysis confirmed spherical shape with size in 19.4±5 nm and investigated the neuroprotective effect in cerebral stroke rats induced by 30 min of carotid artery occlusion followed by 4 hr reperfusion, evaluated by infarction size, ROS/RNS via GSH, MPO, NO estimationand AchE activity, and monitoring EEG function. Cortex and hippocampal histology were compared between groups. AGNP treatment significantly decreased Infarction size and increased GSH levels (p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, SKU College of Pharmaceutical Sciences, S. K. University, Anantapur, India.
- Department of Formulations and Development, Quotient Sciences, Garnet Valley, PA, USA.
- Department of Pharmaceutical Sciences, School of Biotechnology and Pharmaceutical Sciences, Vignan's Foundation for Science, Technology & Research (Deemed to be University), Guntur, India.
- Aura Biosciences Inc., Boston, USA.
- Section of Microbiology, Central Ayurveda Research Institute, Jhansi, Uttar Pradesh, India.
- Department of Pharmacognosy, Nitte College of Pharmaceutical Sciences, Bangalore, India.
Zitieren
APA
Rudrala, L. C., Challa, R. R., Subramanyam, S., Ayyappa Gouru, S., Singh, G., Sirisha Mulukuri, N. V. L., Pasala, P. K., Dintakurthi, P. S. N. B. K., Gajula, S., & Rudrapal, M. (2024). Cerebroprotective Potential of Andrographolide Nanoparticles: In silico and In vivo Investigations. Drug Research, 74(07), 335-346. https://doi.org/10.1055/a-2345-5396
Vancouver
Rudrala LC, Challa RR, Subramanyam S, Ayyappa Gouru S, Singh G, Sirisha Mulukuri NVL, et al. Cerebroprotective Potential of Andrographolide Nanoparticles: In silico and In vivo Investigations. Drug Research. 2024;74(07):335-346. doi:10.1055/a-2345-5396
BibTeX
@article{Rudrala2024,
author = {Rudrala, Lakshmi Charitha and Challa, Ranadheer Reddy and Subramanyam, Sibbala and Ayyappa Gouru, Sampath and Singh, Gagandeep and Sirisha Mulukuri, N V L and Pasala, Praveen Kumar and Dintakurthi, Prasanth Sree Naga Bala Krishna and Gajula, Somasekhar and Rudrapal, Mithun},
title = {Cerebroprotective Potential of Andrographolide Nanoparticles: In silico and In vivo Investigations},
journal = {Drug Research},
year = {2024},
volume = {74},
number = {07},
pages = {335--346},
doi = {10.1055/a-2345-5396}
}
EUVIMED